Poor Ovarian Response Clinical Trial
Official title:
The Clinical Trial of the Effect of Transcutaneous Electrical Acupoint Stimulation on the Quality of the Oocyte on Poor Ovarian Response
Patients in experimental group will be given transcutaneous electrical acupoint stimulation (TEAS) treatment for 12 weeks prior to controlled ovarian stimulation (COS).The patients will be given three times acupuncture every week except menstruation.Patients in no intervention group will not be given any interventions for 12 weeks prior to COS. The primary outcome measure is the number of MII eggs obtained in the COS cycle. The secondary outcome measures are the lab and clinical reproductive outcomes.
The patients will be randomly recruited into two groups. Patients in experimental group will be given TEAS treatment for 12 weeks prior to COS.The patients will be given three times acupuncture every week except menstruation. One treatment lasts for 30 minutes. The acupoints used for the TEAS treatment included head acupoint Baihui(DU20), abdominal acupoint Zhongji (RN3), Guanyuan (RN4), Zigong(EX-CA1), leg acupoint Sanyinjiao(SP6), waist acupoint Shenyu (BL23) and Guanyuanyu(BL26). Patients in no intervention group will not be given any intervention for 12 weeks prior to COS. When at least one dominant follicle is greater than 18 mm then injection a GnRH agonist (Triptorelin, Ferring, Switzerland) 0.2mg. 36 hours later transvaginal oocyte retrieval will be taken. After 3 hours of incubation, each egg will be transferred with a density of about 100,000/mllive sperm. The fresh embryo transfer is performed 72 hours after embryo culture in vitro. The whole embryos will be frozen. The primary outcome measure is the number of MII eggs obtained in the COS cycle. The secondary outcome measures are the lab and clinical reproductive outcomes,including basic endocrine, serum Anti-Mullerian Hormone (AMH), antral follicle counts, fertilization rate, cleavage rate, number of D3 embryos, the clinical pregnancy rate and early abortion rate. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03433768 -
Androgen Receptor mRNA Expression is Positively Associated With Live Birth in Women Undergoing IVF Independently of the Type of Ovarian Response
|
N/A | |
Recruiting |
NCT05601193 -
Ovarian PRP Injection in Women With POR
|
N/A | |
Suspended |
NCT03021915 -
Single Center, Prospective Controlled Pilot Study of the OvaPrime Procedure
|
N/A | |
Completed |
NCT04013984 -
Acupuncture for Treatment of Patients With Poor Ovarian Response
|
N/A | |
Completed |
NCT03447184 -
Long-term Endogenous Androgen Priming in Bologna Criteria Poor Responder Patients - A Pilot Study
|
||
Completed |
NCT01816321 -
Corifollitropin Alfa Followed by Menotropin for Poor Ovarian Responders Trial
|
Phase 3 | |
Recruiting |
NCT04310293 -
Novel Therapy for Poor Responders Management
|
N/A | |
Completed |
NCT05703308 -
Menstrual Blood Stem Cells in Poor Ovarian Responders
|
Phase 3 | |
Terminated |
NCT00878124 -
How Dose Coenzyme Q10 Supplementation During Infertility Treatment Effects Pregnancy Outcome
|
N/A | |
Not yet recruiting |
NCT06089395 -
The Effect of Jiajian Guishen Granules on the Modulation of Ovarian Function in Patients With Poor Ovarian Response(POR)
|
Early Phase 1 | |
Completed |
NCT01732068 -
Treatment of Poor Ovarian Responders With Corifollitropin Alfa Followed by hpHMG in a Short GnRH Agonist Protocol
|
Phase 2 | |
Completed |
NCT01732094 -
Corifollitropin Alfa Followed by hpHMG in a Long GnRH Agonist Protocol for the Treatment of Poor Ovarian Responders
|
Phase 2 | |
Recruiting |
NCT04717752 -
A Randomized Controlled Study of Different Trigger Modes of Antagonist Regimen in Patients With Low Ovarian Reserve
|
N/A | |
Recruiting |
NCT04024722 -
Improving in Vitro Fertilization in Women With Poor Ovarian Response
|
N/A | |
Recruiting |
NCT03830697 -
A Trial Study on Acupuncture Treatment of Poor Ovarian Response
|
N/A | |
Recruiting |
NCT02801591 -
Effect of Recombinant Human Growth Hormone Injection on the Clinical Outcome of POR in Patients Undergoing IVF/ET
|
N/A | |
Recruiting |
NCT04273256 -
Myo-inositol for the Management of Poor Ovarian Responders: A Prospective Randomized Controlled Trial
|
Phase 2/Phase 3 | |
Recruiting |
NCT02993588 -
Impact of Melatonin on IVF/ICSI Outcomes in Prospective Poor Responders
|
Phase 2/Phase 3 | |
Terminated |
NCT02418572 -
Testosterone TRANSdermal Gel for Poor Ovarian Responders Trial
|
Phase 3 |